Mark Bertolini Sells 615,142 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini sold 615,142 shares of the business’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $28.61, for a total transaction of $17,599,212.62. Following the completion of the transaction, the chief executive officer owned 9,581,734 shares of the company’s stock, valued at approximately $274,133,409.74. This represents a 6.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Trading Down 3.1%

Shares of Oscar Health stock opened at $28.54 on Wednesday. The firm has a 50-day simple moving average of $23.56 and a two-hundred day simple moving average of $17.55. The company has a market cap of $8.61 billion, a P/E ratio of -48.38, a price-to-earnings-growth ratio of 2.06 and a beta of 2.37. Oscar Health, Inc. has a fifty-two week low of $10.69 and a fifty-two week high of $30.66. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.11 and a current ratio of 1.11.

Oscar Health (NYSE:OSCR) last posted its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.90 billion. During the same period in the prior year, the company posted $0.92 EPS. The company’s revenue for the quarter was up 52.6% on a year-over-year basis. As a group, equities analysts predict that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Oscar Health

Several large investors have recently bought and sold shares of OSCR. Quarry LP lifted its position in shares of Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after acquiring an additional 1,469 shares in the last quarter. Jones Financial Companies Lllp increased its position in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Strs Ohio acquired a new position in Oscar Health in the 1st quarter valued at $30,000. Fifth Third Bancorp lifted its holdings in Oscar Health by 148.7% in the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after purchasing an additional 1,413 shares in the last quarter. Finally, Binnacle Investments Inc purchased a new position in Oscar Health in the 2nd quarter valued at $75,000. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Wells Fargo & Company set a $20.00 price objective on Oscar Health and gave the company an “equal weight” rating in a research report on Thursday, June 4th. Robert W. Baird increased their target price on Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. UBS Group lifted their price target on shares of Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Zacks Research lowered shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 5th. Finally, Wolfe Research began coverage on shares of Oscar Health in a research report on Tuesday, May 5th. They set a “peer perform” rating for the company. Three research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Oscar Health presently has a consensus rating of “Hold” and a consensus target price of $20.78.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.